Clinical Trials on Left Sided Breast Cancer in Russian Federation
Total 205 results
-
AstraZenecaCompletedAdvanced Breast CancerRussian Federation, Ukraine, Czech Republic
-
AstraZenecaCompletedLINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer (LINE)Local Advanced or Metastatic Postmenopausal Breast CancerRussian Federation
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerSpain, Australia, Belgium, Turkey, Russian Federation
-
Prestige Biopharma LimitedCompletedHER2 Positive Breast CancerSpain, Malaysia, Estonia, Hungary, Thailand, Belarus, Bulgaria, France, Georgia, Italy, Poland, Russian Federation, Ukraine
-
Eli Lilly and CompanyCompletedBreast CancerAustria, Czech Republic, Hungary, Poland, Romania, Russian Federation
-
AstraZenecaRecruiting
-
Eisai LimitedTerminatedMetastatic Breast CancerRussian Federation, United Kingdom, Germany, Italy, Spain
-
BiocadCompletedHuman Epithelial Receptor (HER)-2 Positive Breast CancerUkraine, Russian Federation, Belarus, India
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
Maxygen Holdings Ltd.Parexel; Maxygen ApS; Maxygen, Inc.UnknownBreast Cancer | Chemotherapy-Induced NeutropeniaPoland, Romania, Russian Federation, Ukraine
-
AstraZenecaRecruitingBreast CancerRussian Federation
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedBreast CancerSpain, Poland, Italy, Austria, Russian Federation, Slovakia, Hungary, Germany, Czech Republic, Estonia, Latvia
-
MedSIRCompletedMetastatic Breast CancerSpain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
-
AstraZenecaDaiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerBelgium, United States, Taiwan, Korea, Republic of, Brazil, Russian Federation, Canada, Australia, France, Mexico
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
Hoffmann-La RocheCompletedBreast CancerFrance, Spain, Sweden, Russian Federation, Denmark, Slovakia
-
TakedaCompletedCancer | Break Through PainRussian Federation, Hungary, Norway
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Novartis PharmaceuticalsRecruitingBreast CancerRussian Federation
-
Astellas Pharma IncCompletedBreast CancerUnited States, Ireland, Belgium, Czech Republic, Germany, Poland, Russian Federation, United Kingdom
-
PfizerCompletedEarly Breast CancerCzechia, Serbia, Slovakia, United States, Belarus, Hungary, Ukraine, Italy, Poland, Russian Federation
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
Hoffmann-La RocheCompletedBreast CancerSpain, Russian Federation, Austria, Italy, Germany, Portugal
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedBreast CancerUnited Kingdom, United States, France, Russian Federation, Belgium, Netherlands
-
SanofiTerminatedBreast CancerFrance, Belgium, United States, Italy, Japan, Puerto Rico, Russian Federation, Spain, Ukraine
-
BiogenCompletedBreast CancerUnited States, Russian Federation, Australia, Belgium
-
AstraZenecaRecruiting
-
AstraZenecaDaiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerUnited States, Italy, India, Taiwan, Germany, Korea, Republic of, Brazil, Poland, Russian Federation, Turkey, Spain, Australia, France, Canada, United Kingdom
-
SandozCompletedBreast Cancer | Chemotherapy Associated NeutropeniaCzech Republic, Hungary, Latvia, Russian Federation, Slovakia, Ukraine
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerSouth Africa, France, Italy, Taiwan, Hungary, Belgium, Spain, Austria, Netherlands, Poland, Russian Federation, United States, Argentina, Brazil, Peru
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, China, Hungary, Singapore, Australia, Russian Federation, Hong Kong, Brazil, Croatia, Korea, Republic of
-
Zeno Alpha Inc.CompletedBreast CancerUnited States, Belarus, Bosnia and Herzegovina, Czechia, Hungary, Lithuania, Russian Federation, Serbia, Ukraine
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
EMD SeronoTerminatedBreast CancerCzech Republic, Korea, Republic of, Russian Federation, South Africa, Germany, Slovakia, Austria, United States, Belgium, Poland, Israel, Australia
-
Genentech, Inc.UnknownMetastatic Breast CancerAustralia, Spain, Greece, Mexico, Russian Federation, United States, Singapore, Canada, Peru, Taiwan, Korea, Republic of, Philippines, Netherlands, United Kingdom, France, Brazil, Ukraine, Sweden, Guatemala, Panama, Norway, Uruguay
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
Eli Lilly and CompanyActive, not recruitingMetastatic Breast CancerSpain, Taiwan, United States, Italy, Czechia, Germany, Belgium, Turkey, Brazil, Russian Federation, Argentina, Austria, France, Mexico
-
Fondazione MichelangeloCompletedBreast CancerSpain, Australia, Singapore, Italy, Germany, Russian Federation
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
Bristol-Myers SquibbCompletedBreast CancerUnited States, India, Korea, Republic of, Taiwan, Spain, Germany, Austria, Italy, Peru, Russian Federation, Singapore, France, United Kingdom, Philippines, Argentina
-
Hoffmann-La RocheTerminatedBreast Cancer | Gastric CancerItaly, Argentina, Canada, France, Greece, Portugal, Slovakia, Brazil, Russian Federation, Spain, Germany, Serbia
-
Hoffmann-La RocheCompletedBreast CancerItaly, Spain, China, Taiwan, Russian Federation, Canada, Germany, Austria, Hungary, Belgium, Australia, Brazil, Mexico, Poland, Panama
-
EirGenix, Inc.CompletedBreast CancerTaiwan, India, Georgia, United States, Russian Federation, South Africa, Ukraine, Belarus, Chile, Colombia, Korea, Republic of
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerFrance, Hong Kong, Korea, Republic of, Russian Federation, Spain, United States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, China, Colombia, Croatia, Cyprus, Czech Republic, Egypt, Estonia, ... and more
-
Janssen Research & Development, LLCCompletedPostmenopausal | Metastatic ER+ Her2- Breast CancerUnited States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland